Literature DB >> 1322638

A mitochondrial DNA variant, identified in Leber hereditary optic neuropathy patients, which extends the amino acid sequence of cytochrome c oxidase subunit I.

M D Brown1, C C Yang, I Trounce, A Torroni, M T Lott, D C Wallace.   

Abstract

A G-to-A transition at nucleotide pair (np) 7444 in the mtDNA was found to correlate with Leber hereditary optic neuropathy (LHON). The mutation eliminates the termination codon of the cytochrome c oxidase subunit I (COI) gene, extending the COI polypeptide by three amino acids. The mutation was discovered as an XbaI restriction-endonuclease-site loss present in 2 (9.1%) of 22 LHON patients who lacked the np 11778 LHON mutation and in 6 (1.1%) of 545 unaffected controls. The mutant polypeptide has an altered mobility on SDS-PAGE, suggesting a structural alteration, and the cytochrome c oxidase enzyme activity of patient lymphocytes is reduced approximately 40% relative to that in controls. These data suggest that the np 7444 mutation results in partial respiratory deficiency and thus contributes to the onset of LHON.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1322638      PMCID: PMC1682694     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  27 in total

1.  Southeast Asian mitochondrial DNA analysis reveals genetic continuity of ancient mongoloid migrations.

Authors:  S W Ballinger; T G Schurr; A Torroni; Y Y Gan; J A Hodge; K Hassan; K H Chen; D C Wallace
Journal:  Genetics       Date:  1992-01       Impact factor: 4.562

2.  The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy with the 11778 mutation.

Authors:  N J Newman; M T Lott; D C Wallace
Journal:  Am J Ophthalmol       Date:  1991-06-15       Impact factor: 5.258

3.  Mitochondrial DNA sequence polymorphism, VO2max, and response to endurance training.

Authors:  F T Dionne; L Turcotte; M C Thibault; M R Boulay; J S Skinner; C Bouchard
Journal:  Med Sci Sports Exerc       Date:  1991-02       Impact factor: 5.411

4.  Mitochondrial DNA complex I and III mutations associated with Leber's hereditary optic neuropathy.

Authors:  M D Brown; A S Voljavec; M T Lott; A Torroni; C C Yang; D C Wallace
Journal:  Genetics       Date:  1992-01       Impact factor: 4.562

5.  X chromosome-linked and mitochondrial gene control of Leber hereditary optic neuropathy: evidence from segregation analysis for dependence on X chromosome inactivation.

Authors:  X D Bu; J I Rotter
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

6.  Alternative, simultaneous complex I mitochondrial DNA mutations in Leber's hereditary optic neuropathy.

Authors:  D R Johns; J Berman
Journal:  Biochem Biophys Res Commun       Date:  1991-02-14       Impact factor: 3.575

7.  A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy.

Authors:  K Huoponen; J Vilkki; P Aula; E K Nikoskelainen; M L Savontaus
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

8.  Leber hereditary optic neuropathy: involvement of the mitochondrial ND1 gene and evidence for an intragenic suppressor mutation.

Authors:  N Howell; I Kubacka; M Xu; D A McCullough
Journal:  Am J Hum Genet       Date:  1991-05       Impact factor: 11.025

9.  Sequence and gene organization of mouse mitochondrial DNA.

Authors:  M J Bibb; R A Van Etten; C T Wright; M W Walberg; D A Clayton
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

10.  Optic atrophy in Leber hereditary optic neuroretinopathy is probably determined by an X-chromosomal gene closely linked to DXS7.

Authors:  J Vilkki; J Ott; M L Savontaus; P Aula; E K Nikoskelainen
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

View more
  24 in total

1.  Mitochondrial genetics: principles and practice.

Authors:  J M Shoffner; D C Wallace
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

2.  A variant of Leber hereditary optic neuropathy characterized by recovery of vision and by an unusual mitochondrial genetic etiology.

Authors:  D Mackey; N Howell
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

3.  The diversity present in 5140 human mitochondrial genomes.

Authors:  Luísa Pereira; Fernando Freitas; Verónica Fernandes; Joana B Pereira; Marta D Costa; Stephanie Costa; Valdemar Máximo; Vincent Macaulay; Ricardo Rocha; David C Samuels
Journal:  Am J Hum Genet       Date:  2009-05-07       Impact factor: 11.025

4.  Mitochondrial involvement in schizophrenia and other functional psychoses.

Authors:  S A Whatley; D Curti; R M Marchbanks
Journal:  Neurochem Res       Date:  1996-09       Impact factor: 3.996

Review 5.  Leber's hereditary optic neuropathy: the clinical relevance of different mitochondrial DNA mutations.

Authors:  P Riordan-Eva; A E Harding
Journal:  J Med Genet       Date:  1995-02       Impact factor: 6.318

6.  When does bilateral optic atrophy become Leber hereditary optic neuropathy?

Authors:  N Howell; S Halvorson; J Burns; D A McCullough; J Paulton
Journal:  Am J Hum Genet       Date:  1993-10       Impact factor: 11.025

7.  Pitfalls in the molecular genetic diagnosis of Leber hereditary optic neuropathy (LHON).

Authors:  D R Johns; M J Neufeld
Journal:  Am J Hum Genet       Date:  1993-10       Impact factor: 11.025

8.  Finger prick blood testing in Leber hereditary optic neuropathy.

Authors:  D Mackey; S Nasioulas; S Forrest
Journal:  Br J Ophthalmol       Date:  1993-05       Impact factor: 4.638

9.  Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia.

Authors:  D D De Vries; L N Went; G W Bruyn; H R Scholte; R M Hofstra; P A Bolhuis; B A van Oost
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

Review 10.  Mitochondrial DNA sequence variation in human evolution and disease.

Authors:  D C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.